Skip to main content
Search
Main content
The Journal of experimental medicine
Published

CD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-β

Authors

Vignesh Jayaraman, Ian E Prise, Verena Kästele, Sabrina Tamburrano, Kelly Wemyss, Hayley M Bridgeman, Rufus H Daw, Patrick Strangward, Alfie Sanderson, Sheena M Cruickshank, Joanne E Konkel, Christine Chew, Chengcan Yao, C J Anderson, Josef Priller, Barry McColl, David A D Munro, Liesbet Martens, Charlotte L Scott, Martin Guilliams, Antony D Adamson, John R Grainger, Tovah N Shaw

Abstract

J Exp Med. 2026 May 4;223(5):e20240801. doi: 10.1084/jem.20240801. Epub 2026 Apr 21.

ABSTRACT

Macrophages localize in sub-tissular niches associated with their ontogeny and activity. In the intestine, a paradigm has emerged that long-lived macrophages are present in the muscular layer, while highly monocyte-replenished populations are found in the lamina propria (LP). Whether long-lived macrophages are restricted in such a simplified manner has not been well explored. Moreover, the impact of specific gut-associated factors on macrophage identity across intestinal tissue layers is unknown. We generated scRNA-seq data from WT and Ccr2-/- mice to identify phenotypic features of long-lived macrophage populations in distinct intestinal layers and identified CD163 as a marker to distinguish submucosal/muscularis (S/M) from LP macrophages. Challenging the emerging paradigm, long-lived macrophages were found in the LP and S/M, with distinct transcriptomes and responsiveness to proinflammatory stimuli. Employing transgenic mice, we demonstrate a critical role for TGF-β signalling in maintaining the identity of long-lived LP but not S/M macrophages and that macrophage-derived TGF-β1 is required to instruct intestinal macrophage identity after development.

PMID:42012484 | DOI:10.1084/jem.20240801

UK DRI Authors

Prof Josef Priller

Group Leader

Defining and modulating myeloid cell function in neurodegenerative diseases

Prof Josef Priller

Dr Barry McColl

Group Leader

Investigating the role of microglia in neurodegenerative disease

Dr Barry McColl